Acute graft-versus-host disease (GVHD) is a common immune complication that can occur
after allogeneic haematopoietic cell transplantation (alloHCT). Acute GVHD is a major …

An essential component of allogeneic and autologous hematopoietic cell transplantation
(HCT) is the conditioning regimen administered before the hematopoietic cell infusion. Early …

Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective
adoptive cellular immunotherapy for the treatment of a number of cancers. The …

Background Myeloablative allogeneic hematopoietic stem-cell transplantation is curative in
children with sickle cell disease, but in adults the procedure is unduly toxic. Graft rejection …

Graft-versus-host disease (GVHD) represents the most serious and challenging
complication of allogeneic haematopoietic stem-cell transplantation (HSCT). New insights …

Adenovirus infections occur in 5% to 21% of patients following stem cell transplantation
(SCT), with an associated mortality of up to 50%. However, a lack of prospective studies has …

The development of malignant disease might be seen as a failure of immune surveillance.
However, not all tumors are naturally immunogenic, and even among those that are …

We compared the outcome of nonmyeloablative allogeneic hematopoietic cell
transplantation (HCT) for patients with relapsed or refractory Hodgkin lymphoma (HL) based …

Purpose To analyze the outcome, including nonrelapse mortality (NRM), relapse rate (RR),
progression-free survival (PFS), and overall survival (OS), of patients with diffuse large B-cell …

Purpose Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of malignancies
characterized by a poor prognosis. We performed a pilot study to investigate the role of …